GlassScriptPhysician profile
Alexander Stewart
NPI 1346223013
$76,471.94
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62K · 2020: $8,679 · 2021: $5,916.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $43,711.94 | 2019-2021 | |
| Genzyme Corporation | $17,212.25 | 2019-2021 | |
| Janssen Biotech, INC. | $5,097.26 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $3,900.00 | 2019 | |
| Genentech, INC. | $2,614.67 | 2019 | |
| Secura Bio, INC. | $2,000.00 | 2019 | |
| Janssen Global Services, LLC | $1,750.00 | 2020 | |
| Glaxosmithkline, LLC. | $185.82 | 2020 |
4 companies reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Stewart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.